Azra AI has entered an original equipment manufacturer and reseller agreement with 4DMedical.
Under the agreement, 4DMedical will integrate its CT:VQ quantitative lung imaging analytics software with Azra AI's platform to support care coordination across the following lung health conditions:
COPD and emphysema
Interstitial lung disease (ILD)
Pulmonary nodules
Unexplained breathlessness (dyspnea)
Coronary artery calcium (CAC)
Acute and chronic pulmonary embolism
CT:VQ is a combined ventilation and perfusion imaging algorithm cleared by the U.S. Food and Drug Administration. The companies plan joint sales and go-to-market programs in the coming months, with further details on product integrations to be announced, they said.
